Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$1.35 -0.03 (-2.17%)
As of: Nov 11, 2026 · 3:59 PM EST

Kiora Pharmaceuticals (KPRX) Asset Writedowns and Impairment (2023 - 2025)

Updated

Kiora Pharmaceuticals (KPRX) reported Asset Writedowns and Impairment of $4.62 million for Q4 2025.

Analysis

Kiora Pharmaceuticals (KPRX) Asset Writedowns and Impairment (2023 - 2025) Analysis & Trends

  • Asset Writedowns and Impairment has a four-year compound annual growth rate of 3.4% (FY2021 to FY2025).
  • By year, Asset Writedowns and Impairment came in at $2.01 million in FY2024 (+5.4%), $1.9 million in FY2023 and $4.04 million in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Asset Writedowns and Impairment since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kiora Pharmaceuticals 8.53 Mn -58.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.62 Mn
Sep 30, 2024 2.01 Mn
Sep 30, 2023 1.90 Mn
API Access

Kiora Pharmaceuticals Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=KPRX&period=max&api_key=YOUR_API_KEY